Safety, Tolerability & Pharmacokinetics Study of CNTX-6016 in Healthy Subjects and Subjects With PDN

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2021
A Phase 1b study to evaluate the safety, tolerability and pharmacokinetics of multiple ascending doses of CNTX-6016 in healthy subjects and a single cohort to evaluate painful diabetic neuropathy.
Epistemonikos ID: ffcbc63f9a20281fee1289c08da847efe2b04a85
First added on: Oct 02, 2023